Investigating how cannabis legalization affects tobacco use among youth and adults
Cannabis Legalization's Effects on Youth and Adult Nicotine and Tobacco Use
This study looks at how legalizing recreational cannabis affects tobacco use among both young people and adults, helping us understand if people are using cannabis instead of or alongside tobacco products, so we can give helpful information to those making health policies.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10929558 on NIH RePORTER |
What this research studies
This research examines the impact of recreational cannabis legalization on tobacco product use, focusing on both youth and adults. It aims to understand whether cannabis acts as a substitute or complement to tobacco products, including cigarettes and electronic nicotine delivery systems. By compiling a comprehensive database of cannabis policies and matching it with national survey data, the study seeks to provide insights that can inform policymakers about the health implications of cannabis laws. The findings could help shape regulations that better protect community health.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 20 and under, as well as adults over 21 who use or are affected by tobacco and cannabis products.
Not a fit: Patients who do not use tobacco or cannabis products may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more informed cannabis policies that reduce tobacco use and improve public health outcomes.
How similar studies have performed: While there have been some studies on cannabis and tobacco use, this research aims to fill gaps in understanding the specific effects of cannabis legalization, making it a novel approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Friedman, Abigail S. — Yale University
- Study coordinator: Friedman, Abigail S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.